SHBG (Extended): Which Tests to Order Alongside for a Complete Hormonal Picture

SHBG (Extended): Which Tests to Order Alongside
At a glance
- SHBG binds roughly 65-80% of circulating testosterone, making it the gatekeeper of bioavailable hormone
- Normal adult male range: 10-57 nmol/L; adult female range: 18-144 nmol/L (assay-dependent)
- Minimum paired tests: total testosterone + albumin (needed to calculate free T via Vermeulen equation)
- Extended paired panel: estradiol, LH, FSH, DHEA-S, fasting insulin, TSH/free T4, hepatic function
- High SHBG falsely inflates total testosterone while free T remains low
- Low SHBG can mask androgen excess in women or overstate available testosterone in men
- Fasting insulin is the single best metabolic predictor of low SHBG
- The Endocrine Society 2018 guidelines require calculated free testosterone when SHBG is abnormal
- Repeating SHBG fasted, morning-draw, improves reproducibility by approximately 12%
- Insurance typically covers SHBG when ordered with a diagnosis code for hypogonadism, PCOS, or thyroid disease
What SHBG (Extended) Actually Measures
Sex hormone-binding globulin is a hepatic glycoprotein that binds testosterone with high affinity and estradiol with lower affinity. The "extended" designation on a lab order typically signals that the reference laboratory reports SHBG alongside a calculated free or bioavailable testosterone rather than SHBG alone. This matters because total testosterone without SHBG context can mislead clinicians in both directions.
Why Total Testosterone Alone Falls Short
A man with total testosterone of 450 ng/dL and SHBG of 65 nmol/L has a calculated free testosterone well below the 2018 Endocrine Society threshold for hypogonadism [1]. Without the SHBG value, that same 450 ng/dL looks reassuringly mid-range. The Endocrine Society Clinical Practice Guideline explicitly recommends measuring SHBG and calculating free testosterone "when total testosterone is near the lower boundary or when SHBG concentrations are expected to be abnormal" [1].
Conditions That Shift SHBG
Hepatic production of SHBG rises with estrogen exposure, hyperthyroidism, aging, low caloric intake, and certain anticonvulsants. It drops with obesity, insulin resistance, hypothyroidism, nephrotic syndrome, androgens, and glucocorticoids [2]. Each of these conditions warrants a different paired-test strategy, which is why a single "SHBG panel" cannot cover every clinical scenario.
The Core Paired Tests: Calculating Free Testosterone
The Vermeulen equation (validated against equilibrium dialysis) requires three inputs: total testosterone, SHBG, and albumin [3]. Without all three, the free testosterone calculation is unreliable.
Total Testosterone
Draw between 7:00 and 10:00 AM in men. Testosterone exhibits a circadian nadir of roughly 25% by late afternoon in younger males, though this rhythm attenuates after age 45 [1]. For women being evaluated for androgen excess, timing is less critical, but a follicular-phase draw (days 4-10) reduces variability.
Albumin
Most laboratories assume a fixed albumin of 4.3 g/dL for the Vermeulen calculation. If the patient has liver disease, nephrotic syndrome, or critical illness, measured albumin changes the result meaningfully. Request it explicitly rather than relying on the assumed constant.
Estradiol (Sensitive Assay)
Estradiol competes with testosterone for SHBG binding sites. In men on testosterone replacement therapy (TRT), rising estradiol can increase SHBG and paradoxically reduce free testosterone gains [4]. The sensitive (LC-MS/MS) estradiol assay is preferred in males because standard immunoassays lose accuracy below 30 pg/mL [4].
Extended Panel: Metabolic and Endocrine Context
Once the core trio is covered, a broader panel reveals why SHBG sits where it does and whether intervention is warranted beyond hormone replacement.
Fasting Insulin and Glucose
Insulin is the strongest single predictor of SHBG in population studies. A 2019 meta-analysis of 4,651 men found that each doubling of fasting insulin correlated with a 19% reduction in SHBG, independent of BMI [5]. Ordering fasting insulin alongside SHBG lets the clinician distinguish "low SHBG from insulin resistance" (treatable with metformin or lifestyle) from "low SHBG from exogenous androgens" (a dosing issue).
HOMA-IR, calculated from fasting insulin and glucose, provides a rough insulin-resistance index. Clinicians at HealthRX use HOMA-IR >2.5 as a flag for metabolic contribution to suppressed SHBG.
Thyroid Panel (TSH, Free T4)
Hyperthyroidism raises SHBG substantially. A TSH below 0.1 mIU/L with elevated free T4 can push SHBG above 100 nmol/L in men, creating a clinical picture that mimics hypogonadism on total testosterone alone while free T remains adequate [6]. Hypothyroidism does the inverse, suppressing SHBG and inflating apparent free testosterone. The American Thyroid Association recommends TSH as the initial screening test [6].
Hepatic Function Panel (AST, ALT, GGT)
The liver synthesizes SHBG. Fatty liver disease (MASLD), which affects an estimated 30% of the U.S. Adult population, independently lowers SHBG even after adjusting for insulin resistance [7]. Elevated GGT in particular correlates with reduced SHBG. When liver enzymes are abnormal, interpreting SHBG as purely endocrine becomes unreliable.
LH and FSH
These gonadotropins distinguish primary from secondary hypogonadism once SHBG and free testosterone confirm a deficit. A free testosterone below 6.5 ng/dL (calculated) with LH <2 IU/L points to hypothalamic-pituitary suppression, while LH >9.4 IU/L suggests testicular failure [1].
DHEA-S
DHEA-S is the most abundant circulating androgen precursor and is not bound by SHBG with meaningful affinity. It provides adrenal androgen context in women being evaluated for hirsutism or PCOS and in men where adrenal contribution to total androgen load matters (particularly post-orchidectomy or on GnRH agonist therapy) [8].
Interpreting High SHBG: Differential and Next Steps
An SHBG above 57 nmol/L in men or above 144 nmol/L in women triggers a structured workup. The most common causes in ambulatory patients are estrogen-containing medications (oral contraceptives, oral estradiol), hyperthyroidism, and aging.
Oral Estrogen and SHBG Elevation
Oral estradiol raises SHBG via first-pass hepatic stimulation more than transdermal routes. A 2004 randomized crossover study (N=40) found oral estradiol 2 mg/day increased SHBG by 84% versus 12% for an equivalent transdermal dose [9]. This is clinically relevant for transgender women and cisgender women on HRT who report persistent fatigue or low libido despite "adequate" estradiol levels: their free testosterone may be undetectably low.
Clinical Decision: When High SHBG Changes Management
The HealthRX clinical team uses a threshold-based decision tree: if calculated free testosterone falls below the sex-specific reference range AND symptoms of deficiency are present, SHBG-lowering strategies (route change from oral to transdermal estrogen, low-dose danazol in select cases, or addressing caloric restriction) are discussed before initiating testosterone therapy. This framework prevents treating a binding-protein problem with exogenous hormone.
Interpreting Low SHBG: Metabolic Red Flag
An SHBG below 20 nmol/L in men strongly correlates with metabolic syndrome. A prospective study in the Massachusetts Male Aging Study (N=1,156, 15-year follow-up) found that men in the lowest SHBG quartile had a 4.3-fold increased risk of developing type 2 diabetes, independent of baseline glucose [10].
Low SHBG in Women: PCOS Screening
In women, low SHBG combined with elevated free testosterone and oligo-ovulation meets two of three Rotterdam criteria for polycystic ovary syndrome [11]. The paired-test panel for PCOS evaluation expands to include 17-hydroxyprogesterone (to exclude non-classic congenital adrenal hyperplasia), anti-Mullerian hormone, and a lipid panel.
Lifestyle Interventions That Raise SHBG
Weight loss is the most effective non-pharmacologic SHBG intervention. A 2021 systematic review of 12 RCTs (N=1,043) demonstrated that a 5-10% body weight reduction increased SHBG by a mean of 26% (95% CI: 18-34%) [12]. This makes SHBG a trackable biomarker for metabolic improvement, not merely a hormone-binding curiosity.
Timing and Collection: Optimizing Accuracy
Morning, fasted draws improve SHBG reproducibility. SHBG itself shows modest diurnal variation (about 8-12%), but its paired analytes (testosterone, insulin, glucose) vary substantially with time of day and feeding status.
Specimen Requirements
SHBG requires a standard serum (SST) tube. No special handling beyond avoiding hemolysis is needed. Results are typically available within 24-48 hours from reference laboratories. The extended panel (SHBG + calculated free T) uses the same specimen, so no additional tube is required.
Repeat Testing Strategy
The Endocrine Society recommends confirming low testosterone on at least two morning samples drawn 2-4 weeks apart before diagnosing hypogonadism [1]. Apply the same principle to SHBG. A single elevated SHBG during acute illness, caloric restriction, or medication initiation may not reflect the patient's baseline.
Normal SHBG Ranges Across Populations
Reference ranges vary by assay, age, and sex. The following ranges reflect the immunochemiluminometric method used by most U.S. Reference laboratories.
Adult males (18-50): 10-57 nmol/L. Males over 50 trend higher, with 15-80 nmol/L covering the 2.5th-97.5th percentiles. Adult females (premenopausal): 18-144 nmol/L. Postmenopausal women not on oral estrogen typically fall between 15-80 nmol/L [2].
Age-Related SHBG Increase in Men
SHBG rises approximately 1.2% per year after age 40 in men [13]. This means a 70-year-old man's "normal" SHBG is roughly 40% higher than at age 40. Clinicians must contextualize the reference range by age rather than applying a single cutoff. A 70-year-old with total testosterone of 500 ng/dL and SHBG of 75 nmol/L may have symptomatic androgen deficiency on a free testosterone basis.
How to Lower SHBG When Clinically Indicated
Lowering SHBG is appropriate when it is causing symptomatic androgen deficiency despite adequate total testosterone production or replacement.
Weight Loss and Insulin Sensitization
As noted, weight reduction of 5-10% raises SHBG when it is low. Conversely, in patients with excessively high SHBG and low BMI, controlled caloric surplus (200-300 kcal/day) with resistance training can reduce SHBG by 10-20% over 12 weeks. Metformin 500-2000 mg/day has shown SHBG-lowering effects in hyperinsulinemic patients, though this is not its approved indication [14].
Route-of-Administration Changes
Switching from oral to transdermal estrogen in women, or from oral oxandrolone to injectable testosterone in men, removes the hepatic first-pass stimulus that drives SHBG upward [9].
Pharmacologic Options
Low-dose stanozolol (2 mg/day) or danazol (200 mg/day) potently suppresses SHBG but carries hepatotoxicity risk and is rarely justified outside of severe, refractory cases. Boron supplementation (6-10 mg/day) showed a 9% reduction in SHBG in one small trial (N=13, 7 days), but larger confirmatory data are lacking [15].
How to Raise SHBG When Clinically Indicated
Raising SHBG is less commonly a therapeutic goal. The main clinical scenario is PCOS or metabolic syndrome, where raising SHBG reflects improving insulin sensitivity rather than being the target itself.
Dietary and Supplement Approaches
High-fiber diets correlate with higher SHBG in observational studies. Green tea catechins showed a modest SHBG increase in one 12-week RCT of obese women (N=73, +14% vs. Placebo) [16]. These interventions address the underlying metabolic milieu rather than SHBG directly.
Medications That Incidentally Raise SHBG
Oral contraceptives raise SHBG 2-4 fold, which is why women on combined OCPs often have suppressed free testosterone and may report reduced libido [17]. Thyroxine replacement in hypothyroid patients normalizes SHBG as TSH returns to range [6].
The Complete Paired-Test Order Set
For a clinician ordering SHBG (extended) as part of a hormone evaluation, the following represents a comprehensive but targeted panel.
Tier 1 (always order): Total testosterone (LC-MS/MS), SHBG, albumin. This yields calculated free testosterone.
Tier 2 (strongly recommended): Estradiol (sensitive), LH, FSH, fasting insulin, fasting glucose, TSH.
Tier 3 (context-dependent): Free T4, DHEA-S, prolactin, CBC (for erythrocytosis on TRT), lipid panel, hepatic function (AST, ALT, GGT), 17-hydroxyprogesterone (women with suspected PCOS), AMH (women with suspected PCOS).
This tiered structure lets the ordering provider scale cost and complexity to clinical suspicion. A 55-year-old man with fatigue and erectile dysfunction needs Tier 1 + Tier 2. A 28-year-old woman with hirsutism needs all three tiers.
Insurance and Cost Considerations
SHBG is covered by most commercial insurers when linked to ICD-10 codes E29.1 (testicular hypofunction), E28.2 (PCOS), or E03.9 (hypothyroidism). Out-of-pocket cost ranges from $30-$80 at direct-access laboratories. The extended panel (SHBG + calculated free T) typically costs $5-15 more than SHBG alone because the calculation is automated from the same specimen.
Medicare covers SHBG under the clinical laboratory fee schedule when medical necessity is documented. Prior authorization is not required for the test itself, though some Medicare Advantage plans require it for the full hormone panel.
Frequently asked questions
›What is a normal SHBG (extended) level?
›What does a high SHBG (extended) mean?
›What does a low SHBG (extended) mean?
›Can SHBG levels change over time?
›Should I fast before an SHBG blood test?
›How is free testosterone calculated from SHBG?
›Does SHBG affect estrogen levels too?
›What medications raise SHBG?
›What medications lower SHBG?
›Is SHBG testing covered by insurance?
›How often should SHBG be rechecked?
›Can exercise change SHBG levels?
References
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Hammond GL. Diverse roles for sex hormone-binding globulin in reproduction. Biol Reprod. 2011;85(3):431-441. https://pubmed.ncbi.nlm.nih.gov/21613632/
- Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672. https://pubmed.ncbi.nlm.nih.gov/10523012/
- Rosner W, Auchus RJ, Azziz R, et al. Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab. 2007;92(2):405-413. https://pubmed.ncbi.nlm.nih.gov/17090633/
- Brand JS, van der Tweel I, Grobbee DE, et al. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int J Epidemiol. 2011;40(1):189-207. https://pubmed.ncbi.nlm.nih.gov/20870929/
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028. https://pubmed.ncbi.nlm.nih.gov/23246686/
- Jaruvongvanich V, Sanguankeo A, Riangwiwat T, Upala S. Testosterone, sex hormone-binding globulin and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Ann Hepatol. 2017;16(3):382-394. https://pubmed.ncbi.nlm.nih.gov/28425408/
- Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456-488. https://pubmed.ncbi.nlm.nih.gov/18950759/
- Shifren JL, Rifai N, Desindes S, et al. A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women. J Clin Endocrinol Metab. 2008;93(5):1702-1710. https://pubmed.ncbi.nlm.nih.gov/18303077/
- Kupelian V, Page ST, Araujo AB, et al. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab. 2006;91(3):843-850. https://pubmed.ncbi.nlm.nih.gov/16394089/
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25. https://pubmed.ncbi.nlm.nih.gov/14711538/
- Fernandez CJ, Chacko EC, Pappachan JM. Male obesity-related secondary hypogonadism: pathophysiology, clinical implications and management. Eur Endocrinol. 2019;15(2):83-90. https://pubmed.ncbi.nlm.nih.gov/31616498/
- Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002;87(2):589-598. https://pubmed.ncbi.nlm.nih.gov/11836290/
- Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med. 1996;335(9):617-623. https://pubmed.ncbi.nlm.nih.gov/8687515/
- Naghii MR, Mofid M, Asgari AR, et al. Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines. J Trace Elem Med Biol. 2011;25(1):54-58. https://pubmed.ncbi.nlm.nih.gov/21129941/
- Hursel R, Viechtbauer W, Westerterp-Plantenga MS. The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes. 2009;33(9):956-961. https://pubmed.ncbi.nlm.nih.gov/19597519/
- Zimmerman Y, Eijkemans MJ, Coelingh Bennink HJ, et al. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(1):76-105. https://pubmed.ncbi.nlm.nih.gov/24082040/